Yu, L., Zhang, L., Xu, X., Wang, Z., Zhou, J., Fan, J., . . . Huang, P. Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria. BMJ Publishing Group.
Chicago Style (17th ed.) CitationYu, Lei, et al. Safety and Efficacy of PD-1 Inhibitor (sintilimab) Combined with Transarterial Chemoembolization as the Initial Treatment in Patients with Intermediate-stage Hepatocellular Carcinoma Beyond Up-to-seven Criteria. BMJ Publishing Group.
MLA (9th ed.) CitationYu, Lei, et al. Safety and Efficacy of PD-1 Inhibitor (sintilimab) Combined with Transarterial Chemoembolization as the Initial Treatment in Patients with Intermediate-stage Hepatocellular Carcinoma Beyond Up-to-seven Criteria. BMJ Publishing Group.